Kazuhiro Shiizaki Selected Research

Vascular Calcification

1/2018	Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease.
1/2010	Reduced expression of perlecan in the aorta of secondary hyperparathyroidism model rats with medial calcification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuhiro Shiizaki Research Topics

Disease

15	Secondary Hyperparathyroidism 06/2016 - 03/2003
6	Chronic Renal Insufficiency 01/2021 - 10/2004
6	Uremia 10/2011 - 09/2003
6	Hyperplasia 08/2008 - 09/2003
5	Neoplasms (Cancer) 01/2021 - 01/2006
4	Inflammation (Inflammations) 01/2020 - 07/2013
4	Fibrosis (Cirrhosis) 01/2018 - 03/2011
4	Hypercalcemia (Milk Alkali Syndrome) 10/2012 - 03/2003
3	Hyperphosphatemia 06/2016 - 03/2003
3	Hepatocellular Carcinoma (Hepatoma) 01/2013 - 12/2005
2	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2011
2	Atrophy 01/2018 - 04/2009
2	Vascular Calcification 01/2018 - 01/2010
2	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2018 - 06/2016
2	Hypocalcemia 06/2016 - 03/2003
2	Carcinogenesis 07/2013 - 01/2006
2	Hyperparathyroidism 10/2011 - 01/2010
1	Bone Resorption 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Disease Progression 12/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Cysts 11/2018
1	Familial Hypophosphatemia (Phosphate Diabetes) 11/2018
1	Autosomal Dominant Polycystic Kidney (ADPKD) 11/2018
1	Kidney Diseases (Kidney Disease) 04/2018
1	Cholangiocarcinoma 01/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Obesity 01/2017
1	Gastritis 10/2014
1	Premature Aging 10/2012
1	Ureteral Obstruction 03/2011
1	Infections 08/2010

Drug/Important Bio-Agent (IBA)

7	Phosphates (Orthophosphate)IBA 01/2020 - 10/2011
7	CalciumIBA 01/2018 - 03/2003
7	Vitamin D FDA LinkGeneric 10/2012 - 03/2003
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2009
5	Parathyroid Hormone (Parathormone)IBA 01/2018 - 03/2003
5	maxacalcitolIBA 11/2009 - 09/2003
4	Calcitriol (Calcijex)FDA LinkGeneric 10/2011 - 06/2003
4	Phosphorus (Red Phosphorus)IBA 01/2010 - 03/2003
3	Pharmaceutical PreparationsIBA 01/2020 - 02/2005
3	fibroblast growth factor 21IBA 12/2019 - 01/2017
3	LigandsIBA 01/2019 - 09/2005
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2019 - 07/2013
3	Fibroblast Growth Factor-23IBA 11/2018 - 10/2012
3	Hormones (Hormone)IBA 04/2018 - 01/2017
3	DioxinsIBA 01/2013 - 12/2005
3	Polychlorinated Dibenzodioxins (TCDD)IBA 01/2013 - 01/2006
3	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 04/2009 - 12/2005
3	Calcium-Sensing ReceptorsIBA 01/2008 - 10/2004
2	CateninsIBA 01/2019 - 07/2013
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018 - 01/2018
2	MineralsIBA 06/2016 - 10/2012
2	Omeprazole (Prilosec)FDA LinkGeneric 10/2014 - 11/2008
2	Benzo(a)pyreneIBA 01/2013 - 11/2008
2	SaltsIBA 10/2003 - 03/2003
1	calcium phosphateIBA 01/2021
1	tartaric acid (tartrate)FDA Link 01/2021
1	AcidsIBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2020
1	Polytetrafluoroethylene (Teflon)FDA Link 11/2018
1	Glutathione Peroxidase GPX1IBA 01/2018
1	Superoxide Dismutase-1IBA 01/2018
1	CatalaseIBA 01/2018
1	AntioxidantsIBA 01/2018
1	Peroxiredoxin IIIIBA 01/2018
1	EnzymesIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Methylene Chloride (Dichloromethane)IBA 01/2017
1	propylene dichlorideIBA 01/2017
1	1,25-dihydroxyvitamin DIBA 06/2016
1	Peptidylprolyl Isomerase (Prolyl Isomerase)IBA 01/2016
1	SodiumIBA 07/2015
1	Proton Pump InhibitorsIBA 10/2014
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 07/2013
1	InterleukinsIBA 07/2013
1	XenobioticsIBA 07/2013
1	interleukin-1beta-converting enzyme inhibitorIBA 07/2013
1	InflammasomesIBA 07/2013
1	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA 01/2013
1	Epoxy Compounds (Epoxides)IBA 01/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2013
1	DNA AdductsIBA 01/2013
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2013
1	LipidsIBA 10/2011
1	Cinacalcet (Sensipar)FDA Link 10/2011
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 03/2011
1	Complementary DNA (cDNA)IBA 08/2010
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2010
1	perlecanIBA 01/2010

Therapy/Procedure

5	Therapeutics 12/2010 - 06/2003
2	Renal Dialysis (Hemodialysis) 01/2017 - 02/2005
1	Peritoneal Dialysis 01/2021
1	Parathyroidectomy 01/2018
1	Kidney Transplantation 01/2018
1	Drug Therapy (Chemotherapy) 12/2010
1	Aftercare (After-Treatment) 08/2010